These markets have transformed from a slow-paced and price-competitive industry to a cutting-edge, technology-driven one with much greater commercial attraction. This report from Frost & Sullivan offers the most current information available on the cancer, AIDS, and autoimmune disease therapeutic vaccine markets. Trends like the potential development of drug resistance in AIDS are discussed. And profiles of companies like Genzyme, Cell Genesys, VaxGen, and SmithKline Beecham are included.
